Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'

기사 요약

Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevity and aesthetics.